CAN FITE (Israel) Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>CAN</div>
Analyze Filter   Check how we calculate scores
Equity ratings for CAN FITE BIOPHARMA are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 30, 2019 and ending today January 28, 2020. Click here to learn more.
CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

CAN FITE Profile

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. CAN FITE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 7 people.. The public information regarding CAN FITE BIOPHARMA's current market price is not available at this time.
Legal NameCAN FITE BIOPHARMA
CEO, DirectorPnina FishmanView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
CAN FITE BIOPHARMA (CANF) is traded on Tel Aviv Stock Exchange in Israel and employs 7 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.42 B. CAN FITE BIOPHARMA operates under Healthcare sector and is part of Biotechnology industry. The entity has 0 outstanding shares. CAN-FITE BIOPHARMA has accumulated about 3.21 M in cash with (4.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Check CAN FITE Probability Of Bankruptcy

CAN FITE Against Markets

CAN FITE BIOPHARMA cannot be verified against its exchange. It appears that CAN FITE is not available for investing at the moment. Please verify the symbol is currently traded on Tel Aviv Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

CAN FITE Corporate Executives

See also Trending Equities. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit